CLBAX | CMALX | CLBAX / CMALX | |
Total Expense Ratio | 0.58 | 1.00 | 58% |
Annual Report Gross Expense Ratio | 0.58 | 1.24 | 47% |
Fund Existence | 24 years | 8 years | - |
Gain YTD | 9.747 | 3.933 | 248% |
Front Load | 4% | N/A | - |
Min. Initial Investment | 250 | 10000 | 3% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 256B | 156M | 164,103% |
Annual Yield % from dividends | 1.82 | 4.10 | 44% |
Returns for 1 year | 7.96 | 6.71 | 119% |
Returns for 3 years | 30.56 | 17.06 | 179% |
Returns for 5 years | 39.83 | 50.21 | 79% |
Returns for 10 years | 78.78 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
MIDGX | 29.64 | N/A | N/A |
MFS International New Discovery R1 | |||
VLCGX | 17.82 | N/A | N/A |
VALIC Company I Large Capital Growth | |||
MFMIX | 17.79 | N/A | N/A |
Morgan Stanley Inst Next Gen Em Mkts I | |||
TNRAX | 20.54 | N/A | N/A |
1290 Avantis U.S. Large Cap Growth A | |||
RYPCX | 7.09 | -0.08 | -1.12% |
Royce Small-Cap Fund Consult |